>약물-장치 조합 시장, 제품별(자동 주사기, 미세 바늘 패치, 디지털 알약, 스마트 흡입기, 약물 전달 하이드로젤, 약물 방출 렌즈 및 기타), 적용 유형별(정형외과 질환, 호흡기 질환, 당뇨병, 종양학, 심혈관 질환 및 기타), 최종 사용자(진료소, 병원, 가정 간병 시설, 외래 진료 센터 및 기타), 유통 채널(직접 입찰, 소매 판매 및 기타), 국가별(중국, 한국, 일본, 인도, 호주, 싱가포르, 말레이시아, 인도네시아, 태국, 필리핀 및 아시아 태평양 지역) 산업 동향 및 2028년까지의 예측.
시장 분석 및 통찰력: 아시아 태평양 약물-장치 조합 시장
약물-장치 조합 시장은 2021년에서 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년에서 2028년까지의 예측 기간 동안 9.3%의 CAGR로 성장하고 있으며 2020년의 1,703.67백만 달러에서 2028년까지 3,332.81백만 달러에 도달할 것으로 예상된다고 분석합니다. 만성 질환 부담의 증가와 더 나은 약물-장치 조합에 대한 수요 증가는 예측 기간 동안 시장 수요를 견인하는 주요 요인입니다.
만성 질환의 증가와 기술의 발전은 약물-장치 조합 시장의 성장에 효과적으로 도움이 됩니다. 그러나 의료 기기와 관련된 한계와 합병증은 의료 기기 시장의 미래 성장을 방해할 수 있습니다. 주요 시장 참여자의 파트너십과 협력은 약물-장치 조합 시장의 성장에 기회로 작용합니다. 그러나 엄격한 규제 프레임워크는 약물-장치 조합 시장의 성장에 도전이 됩니다.
약물-장치 조합 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향에 대한 세부 정보를 제공하고, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서 기회를 분석합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 저희에게 연락하세요. 저희 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드릴 것입니다.
아시아 태평양 약물-장치 조합 시장 범위 및 시장 규모
약물-의료기기 조합 시장은 제품, 응용 분야, 최종 사용자, 유통 채널을 기준으로 4가지 주요 부문으로 분류됩니다.
- 제품 기준으로 약물-장치 조합 시장은 자동 주사기, 마이크로니들 패치, 디지털 알약, 스마트 흡입기, 약물 전달 하이드로젤, 약물 방출 렌즈 등으로 세분화됩니다. 2021년에는 자동 주사기가 약물-장치 조합 시장에서 가장 높은 점유율을 차지했는데, 이는 의료 제품 개발에 대한 정부 지원이 증가하고 대중 사이에서 사용에 대한 일반적인 인식이 높아졌기 때문입니다.
- On the basis of application, the drug-device combination market is segmented into orthopedic diseases, respiratory diseases, diabetes, oncology, cardiovascular diseases, and others. In 2021 orthopedic diseases dominate the drug-device combination market due to the growing demand for highly advanced and efficient drug-device combination products for treatment.
- On the basis of end user, the drug-device combination market is segmented into clinics, hospitals, home care settings, ambulatory care centers, and others. In 2021, the clinics are expected to dominate the drug-device combination market due to the increasing number of specialty clinics worldwide. Furthermore, the growing demand for various drug-delivery devices serves as another driving factor.
- On the basis of distribution channel, the drug-device combination market is segmented into direct tender, retail sales, and others. In 2021, direct tender is expected to dominate the drug-device combination market due to the increasing number of hospitals in developed and developing countries, which increases the sales of direct tender and escalates the growth of the market.
Asia-Pacific Drug-Device Combination Market Country Level Analysis
The drug-device combination market is analyzed, and market size information is provided by product, application, end user, and distribution channel.
The countries covered in the drug-device market report are China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific.
Asia-Pacific is expected to grow with the fastest CAGR in the forecasted periods. In Asia-Pacific, countries that demand drug-device combination are increasing rapidly due to increasing population and healthcare expenditure. China is expected to dominate in Asia-Pacific market. China is one of the leading countries in the Asia-Pacific, which utilizes advanced drug-device combination products in the treatment and monitoring of disease.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
Strategic Initiatives by Manufactures is Creating New Opportunities for Players in the Drug-Device Combination Market
약물-장치 조합 시장은 또한 모든 국가의 성장에 대한 자세한 시장 분석을 제공합니다. 게다가 아시아 태평양 지역의 시장 참여자들 간의 의료 장치 판매, 파트너십, 인수, 유통 계약의 성장에 대한 자세한 데이터를 제공합니다. 이 데이터는 2010년부터 2019년까지의 과거 기간에 대한 것입니다.
경쟁 환경 및 약물-장치 조합 시장 - 점유율 분석
약물-장치 조합 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭 및 범위, 응용 프로그램 우세, 기술 수명선 곡선이 있습니다. 위에 제공된 데이터 포인트는 약물-장치 조합 시장과 관련된 회사의 초점에만 관련이 있습니다.
보고서에서 다루는 주요 기업은 Medtronic, GlaxoSmithKline plc, BD, Janssen Pharmaceuticals, Inc., Bayer AG, YPSOMED, CosMED Pharmaceutical Co. Ltd., Otsuka America Pharmaceutical, Inc, VAXXAS, Raphas Co., Ltd., Zimmer Biomet, SONCEBOZ, CGbio, EOFLOW CO.,LTD 등이며, 국내 및 아시아 태평양 지역 기업입니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.
전 세계 여러 회사에서 많은 계약과 제품 출시가 이루어지면서 약물-의료기기 결합 시장이 가속화되고 있습니다.
예를 들어,
- 2020년 11월, YPSOMED는 SCHOTT 및 Lonza와 협력하여 피하 자가 주사를 기반으로 하는 웨어러블 패치 주입기와 복합 제품을 위한 포괄적인 솔루션을 개발했습니다. 이를 통해 회사는 임상 시험에 들어가 제품을 더 빨리 마케팅할 수 있었고, 이는 시장을 활성화했습니다.
- 2017년 6월, CosMED Pharmaceutical Co. Ltd.는 마이크로니들 헤어 그로어(fa:sa)를 출시하고 판매를 시작했습니다. 이를 통해 마이크로니들 기술 분야에서 회사의 성장이 강화되었습니다.
협력, 합작투자 및 기타 시장 참여자의 전략은 의료 기기 시장에서 회사의 인상을 강화하며, 이는 조직의 매출 성장을 개선하는 데에도 도움이 됩니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PATENT ANALYSIS
4.1.1 MANUFACTURING PROCESS OF COMBINATION PRODUCTS
4.1.2 APPROVAL BY AGENCY
4.1.3 PATENT GRANT
4.1.4 PATENT CERTIFICATIONS:
5 PIPELINE ANALYSIS
6 REGULATORY FRAMEWORKS:
6.1 U.S.
6.2 EUROPE
6.3 CANADA
6.4 AUSTRALIA
6.5 JAPAN
6.6 CHINA
6.7 SOUTH KOREA
7 REGIONAL SUMMARY
7.1 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET
7.1.1 OVERVIEW
7.2 EUROPE DRUG-DEVICE COMBINATION MARKET
7.2.1 OVERVIEW
7.3 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET
7.3.1 OVERVIEW
7.4 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET
7.4.1 OVERVIEW
7.5 SOUTH AMERICA DRUG-DEVICE COMBINATION MARKET
7.5.1 OVERVIEW
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
8.1.2 GROWING GERIATRIC POPULATION
8.1.3 ESCALATION IN INNOVATION AND TECHNOLOGIES
8.1.4 RISING RATES OF OBESITY
8.2 RESTRAINTS
8.2.1 PRODUCT RECALLS
8.2.2 RISK ASSOCIATED WITH THE COMBINATION PRODUCTS
8.3 OPPORTUNITIES
8.3.1 RISING EXPENDITURE ON HEALTHCARE
8.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
8.3.3 GROWING SUPPORT BY HEALTHCARE ORGANIZATIONS AND GOVERNMENT BODIES
8.3.4 INCREASE IN R&D ACTIVITIES BY MEDICAL DEVICE COMPANIES
8.4 CHALLENGE
8.4.1 STRICT REGULATORY FRAMEWORK
9 IMPACT OF COVID-19 PANDEMIC ON THE ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET
9.1 IMPACT ON PRICE
9.2 IMPACT ON SUPPLY CHAIN
9.3 IMPACT ON DEMAND
9.4 STRATEGIC DECISIONS FOR MANUFACTURERS
9.5 CONCLUSION
10 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY PRODUCT
10.1 OVERVIEW
10.2 AUTO-INJECTOR
10.2.1 WEARABLE AUTO-INJECTOR
10.2.2 HAND HELD AUTO-INJECTOR
10.3 MICRONEEDLE PATCH
10.4 DIGITAL PILL
10.5 SMART INHALER
10.6 DRUG DELIVERY HYDROGELS
10.7 DRUG-ELUTING LENS
10.8 OTHERS
11 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 ORTHOPEDIC DISEASES
11.3 RESPIRATORY DISEASES
11.4 DIABETES
11.5 ONCOLOGY
11.6 CARDIOVASCULAR DISEASES
11.7 OTHERS
12 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY END USER
12.1 OVERVIEW
12.2 CLINICS
12.3 HOSPITALS
12.4 HOME CARE SETTINGS
12.5 AMBULATORY CARE CENTERS
12.6 OTHERS
13 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 RETAILS SALES
13.4 OTHERS
14 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY REGION
14.1 ASIA-PACIFIC
14.1.1 JAPAN
14.1.2 CHINA
14.1.3 SOUTH KOREA
14.1.4 INDIA
14.1.5 AUSTRALIA
14.1.6 SINGAPORE
14.1.7 THAILAND
14.1.8 MALAYSIA
14.1.9 INDONESIA
14.1.10 PHILIPPINES
14.1.11 REST OF ASIA-PACIFIC
15 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 JANSSEN PHARMACEUTICALS, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 AMGEN INC.
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 GLAXOSMITHKLINE PLC
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENT
17.4 BD
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENTS
17.5 MEDTRONIC
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 COMPANY SHARE ANALYSIS
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENTS
17.6 BAYER AG
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 CGBIO
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENTS
17.8 COSMED PHARMACEUTICAL CO.LTD.
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENTS
17.9 E3D ELCAM DRUG DELIVERY DEVICES
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENTS
17.1 EITAN MEDICAL
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENTS
17.11 EOFLOW CO., LTD.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENTS
17.12 FINDAIR SP. Z O. O.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 INSULET CORPORATION
17.13.1 COMPANY SNAPSHOT
17.13.2 REVENUE ANALYSIS
17.13.3 PRODUCT PORTFOLIO
17.13.4 RECENT DEVELOPMENT
17.14 MEDIPRINT
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENT
17.15 METP PHARMA AG
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 MICRON BIOMEDICAL, INC.
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENTS
17.17 NANOPASS
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENT
17.18 OCUMEDIC
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENT
17.19 OTSUKA AMERICA PHARMACEUTICAL, INC.
17.19.1 COMPANY SNAPSHOT
17.19.2 REVENUE ANALYSIS
17.19.3 PRODUCT PORTFOLIO
17.19.4 RECENT DEVELOPMENT
17.2 PROPELLER HEALTH
17.20.1 COMPANY SNAPSHOT
17.20.2 REVENUE ANALYSIS
17.20.3 PRODUCT PORTFOLIO
17.20.4 RECENT DEVELOPMENT
17.21 RAPHAS CO., LTD.
17.21.1 COMPANY SNAPSHOT
17.21.2 REVENUE ANALYSIS
17.21.3 PRODUCT PORTFOLIO
17.21.4 RECENT DEVELOPMENT
17.22 SENSIRION AG SWITZERLAND
17.22.1 COMPANY SNAPSHOT
17.22.2 REVENUE ANALYSIS
17.22.3 PRODUCT PORTFOLIO
17.22.4 RECENT DEVELOPMENT
17.23 . SONCEBOZ
17.23.1 COMPANY SNAPSHOT
17.23.2 PRODUCT PORTFOLIO
17.23.3 RECENT DEVELOPMENT
17.24 SUBCUJECT APS
17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENT
17.25 THERAJECT
17.25.1 COMPANY SNAPSHOT
17.25.2 PRODUCT PORTFOLIO
17.25.3 RECENT DEVELOPMENT
17.26 VAXESS TECHNOLOGIES INC.
17.26.1 COMPANY SNAPSHOT
17.26.2 PRODUCT PORTFOLIO
17.26.3 RECENT DEVELOPMENTS
17.27 VAXXAS
17.27.1 COMPANY SNAPSHOT
17.27.2 PRODUCT PORTFOLIO
17.27.3 RECENT DEVELOPMENTS
17.28 YPSOMED
17.28.1 COMPANY SNAPSHOT
17.28.2 REVENUE ANALYSIS
17.28.3 PRODUCT PORTFOLIO
17.28.4 RECENT DEVELOPMENTS
17.29 ZIMMER BIOMET
17.29.1 COMPANY SNAPSHOT
17.29.2 REVENUE ANALYSIS
17.29.3 PRODUCT PORTFOLIO
17.29.4 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
표 목록
TABLE 1 ASIA-PACIFIC DRUG-DEVICE COMIBINATION MARKET, PIPELINE ANALYSIS
TABLE 2 MOST OBESE COUNTRIES OF ASIA-PACIFIC 2020
TABLE 3 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 4 ASIA-PACIFIC AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 5 ASIA-PACIFIC AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 6 ASIA-PACIFIC MICRONEEDLE PATCH IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 7 ASIA-PACIFIC DIGITAL PILL IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 8 ASIA-PACIFIC SMART INHALER IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 9 ASIA-PACIFIC DRUG DELIVERY HYDROGELS IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 10 ASIA-PACIFIC DRUG-ELUTING LENS IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 11 ASIA-PACIFIC OTHERS IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 12 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 13 ASIA-PACIFIC ORTHOPEDIC DISEASES IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 14 ASIA-PACIFIC RESPIRATORY DISEASES IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 15 ASIA-PACIFIC DIABETES IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 16 ASIA-PACIFIC ONCOLOGY IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 17 ASIA-PACIFIC CARDIOVASCULAR DISEASES IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 18 ASIA-PACIFIC OTHERS IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 19 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 20 ASIA-PACIFIC CLINICS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 ASIA-PACIFIC HOSPITALS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA-PACIFIC HOME CARE SETTINGS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 ASIA-PACIFIC AMBULATORY CARE CENTERS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 ASIA-PACIFIC AMBULATORY CARE CENTERS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)
TABLE 26 ASIA-PACIFIC DIRECT TENDER IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 ASIA-PACIFIC RETAIL SALES IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 ASIA-PACIFIC OTHERS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 30 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 31 ASIA-PACIFIC AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 32 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 33 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 34 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 35 JAPAN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 36 JAPAN AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 37 JAPAN DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 38 JAPAN DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 39 JAPAN DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 40 CHINA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 41 CHINA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 42 CHINA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 43 CHINA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 44 CHINA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 45 SOUTH KOREA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 46 SOUTH KOREA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 47 SOUTH KOREA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 48 SOUTH KOREA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 49 SOUTH KOREA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 50 INDIA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 51 INDIA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 52 INDIA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 53 INDIA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 54 INDIA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 55 AUSTRALIA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 56 AUSTRALIA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 57 AUSTRALIA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 58 AUSTRALIA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 59 AUSTRALIA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 60 SINGAPORE DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 61 SINGAPORE AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 62 SINGAPORE DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 63 SINGAPORE DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 64 SINGAPORE DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 65 THAILAND DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 66 THAILAND AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 67 THAILAND DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 68 THAILAND DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 69 THAILAND DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 70 MALAYSIA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 71 MALAYSIA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 72 MALAYSIA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 73 MALAYSIA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 74 MALAYSIA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 75 INDONESIA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 76 INDONESIA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 77 INDONESIA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 78 INDONESIA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 79 INDONESIA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 80 PHILIPPINES DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 81 PHILIPPINES AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 82 PHILIPPINES DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 83 PHILIPPINES DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 84 PHILIPPINES DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 85 REST OF ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
그림 목록
FIGURE 1 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: MULTIVARIATE MODELLING
FIGURE 7 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: PRODUCT TYPE LIFELINE CURVE
FIGURE 8 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: DBMR MARKET POSITION GRID
FIGURE 10 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: VENDOR SHARE ANALYSIS
FIGURE 12 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: SEGMENTATION
FIGURE 13 THE INCREASING PREVALENCE OF CHRONIC DISEASES AND RISING GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 THE AUTO-INJECTOR SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET IN THE YEAR 2021 & 2028
FIGURE 15 PORTER'S 5 FORCES
FIGURE 16 PESTEL'S MODEL
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET
FIGURE 18 PREVALENCE OF ASTHMA IN THE FOLLOWING COUNTRIES.
FIGURE 19 INCIDENCE OF CANCER, WHICH INCREASES WITH AGE
FIGURE 20 AGEING POPULATION IN THE WORLD (IN MILLIONS)
FIGURE 21 NORTH AMERICA AGEING POPULATION (IN MILLION)
FIGURE 22 EUROPE AGEING POPULATION (IN MILLION)
FIGURE 23 ASIA-PACIFIC AGEING POPULATION (IN MILLION)
FIGURE 24 MEDICAL DEVICE SPENDING VS. NATIONAL HEALTH EXPENDITURES, 2016
FIGURE 25 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, 2020
FIGURE 26 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, 2019-2028 (USD MILLION)
FIGURE 27 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, CAGR (2021-2028)
FIGURE 28 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 29 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, 2020
FIGURE 30 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, 2019-2028 (USD MILLION)
FIGURE 31 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 32 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 33 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY END USER, 2020
FIGURE 34 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, 2021-2028 (USD MILLION)
FIGURE 35 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, CAGR (2021-2028)
FIGURE 36 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 37 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 38 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 39 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 40 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 41 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: SNAPSHOT (2020)
FIGURE 42 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020)
FIGURE 43 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2021 & 2028)
FIGURE 44 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020 & 2028)
FIGURE 45 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY PRODUCT (2021-2028)
FIGURE 46 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: COMPANY SHARE 2020 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
